CAS 89105-94-2

L-Valine,L-histidyl-L-histidyl-L-leucylglycylglycyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanylglycyl-L-a-aspartyl-

Description:

The chemical substance with the name "L-Valine, L-histidyl-L-histidyl-L-leucylglycylglycyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanylglycyl-L-a-aspartyl-" and CAS number 89105-94-2 is a complex peptide composed of multiple amino acids. This substance is characterized by its sequence of amino acids, which includes L-Valine, L-Histidine, L-Leucine, Glycine, L-Alanine, L-Lysine, L-Glutamine, and L-Aspartic acid. Peptides like this one are typically formed through peptide bonds between the carboxyl group of one amino acid and the amino group of another, resulting in a chain that can exhibit various biological activities. The specific arrangement of amino acids influences the peptide's properties, such as solubility, stability, and potential biological functions. Additionally, peptides can play crucial roles in various physiological processes, including hormone regulation, immune response, and cellular signaling. The complexity of this particular peptide suggests it may have specialized functions in biological systems, although further research would be necessary to elucidate its specific roles and applications.

Formula: C₅₀H₈₀N₁₈O₁₆

Synonyms:

• L-Valine,N-[N-[N-[N-[N2-[N2-[N-[N-[N-[N-(N-L-histidyl-L-histidyl)-L-leucyl]glycyl]glycyl]-L-alanyl]-L-lysyl]-L-glutaminyl]-L-alanyl]glycyl]-L-a-aspartyl]-
• Fibrinogen g-chain fragment analog
• Fibrinogen-binding inhibitor peptide
• Human fibrinogen g-400-411 peptide
• 10: PN: JP2002320666SEQID: 10 claimed protein
• 125: PN: WO2008058016 SEQID: 126 claimed protein
• 1: PN: US7049140 SEQID: 1 claimed protein
• 29: PN: WO0155210 SEQID: 29 unclaimedsequence
• 4: PN: WO2004058305 PAGE: 39 claimed protein
• 6: PN: WO0066182 SEQID: 1 claimedprotein
• His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val
• 15: PN: US20070065361SEQID: 16 unclaimed sequence
• 3: PN: WO02072619PAGE: 8 unclaimed sequence
• 16: PN: US20040191249 SEQID: 16 claimed sequence
• 126: PN: US20030225251 SEQID: 134 claimed sequence
• 4:PN: WO2005035002 PAGE: 8 unclaimed sequence
• 1: PN: WO2004069862 SEQID: 1unclaimed sequence
• 7: PN: US20060046271 SEQID: 19 unclaimed sequence
• 24: PN: WO2004069875 PAGE: 69 claimed sequence
• 29: PN:US7521540 SEQID: 29 unclaimed sequence
• 32: PN: US6790606 SEQID: 29 unclaimed sequence
• FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE
• HHLGGAKQAGDV
• L-Valine, L-histidyl-L-histidyl-L-leucylglycylglycyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanylglycyl-L-α-aspartyl-
• fibrinogen-γ fragment 400-411
• H-HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL-OH
• HUMAN FIBRINOGEN-GAMMA FRAGMENT 400-411
• FIBRINOGEN Y-CHAIN DODECAPETIDE
• Fibrinogen Binding Inhibitor Peptide,HHLGGAKQAGDV

HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL

CAS: 89105-94-2

Formula: C₅₀H₈₀N₁₈O₁₆

Purity: 98%

Molecular weight: 1189.2812

Ref: IN-DA00GRZP

Fibrinogen Binding Inhibitor Peptide

CAS: 89105-94-2

Synthetic dodecapeptide mimics human fibrinogen g-chain, inhibits platelet receptor (residues 400-411).

Formula: C₅₀H₈₀N₁₈O₁₆

Purity: 98%

Color and Shape: Solid

Molecular weight: 1189.28

Ref: TM-TP1778

Fibrinogen-Binding Inhibitor Peptide

CAS: 89105-94-2

The synthetic dodecapeptide HHLGGAKQAGDV represents the specific platelet receptor recognition site of the human fibrinogen γ chain (residues 400-411). It is a potent inhibitor of the binding of fibrinogen, fibronectin, and von Willebrand factor to thrombin- or ADP-stimulated platelets. The peptide has also been used in studying phosphorylation processes associated with platelet activation.

Formula: C₅₀H₈₀N₁₈O₁₆

Purity: > 98%

Molecular weight: 1189.3

Ref: 01-4015549